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NO or its derivatives (reactive nitrogen species, RNS) inhibit mitochondrial complex I by several different mechanisms that are not well
characterised. There is an inactivation by NO, peroxynitrite and S-nitrosothiols that is reversible by light or reduced thiols, and therefore may be
due to S-nitrosation or Fe-nitrosylation of the complex. There is also an irreversible inhibition by peroxynitrite, other oxidants and high levels of
NO, which may be due to tyrosine nitration, oxidation of residues or damage of iron sulfur centres. Inactivation of complex I by NO or RNS is
seen in cells or tissues expressing iNOS, and may be relevant to inflammatory pathologies, such as septic shock and Parkinson’s disease.
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Mitochondrial respiratory complex I (NADH:ubiquinone
oxidoreductase) is a large and complex enzyme coupling
electron transfer to pumping of protons across the mito-
chondrial inner membrane (reviewed in Refs. [1,2]). Bovine
heart complex I has been found to contain 45–46 subunits,
FMN, about eight iron–sulfur clusters and one or more
ubiquinone binding sites. All cofactors are located on 14
(‘‘core’’) subunits that are sufficient for catalysis of energy
transduction by complex I. The remaining subunits are
thought to be involved in assembly of the complex, in
maintaining its stability or in regulation of the activity.
The main function of complex I is transfer of electrons
from NADH to ubiquinone in a reaction that is coupled to
translocation of protons across the mitochondrial inner
membrane. However, recently it has been suggested that
complex I might have some additional functions. The SDAP0005-2728/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: gcb@mole.bio.cam.ac.uk (G.C. Brown).subunit of complex I has been identified as an acyl carrier
protein [3] and might be involved in biosynthesis of lipoic
acid. There are also three possible links between complex I
functions and cell death. Complex I is an important source
of production of reactive oxygen species (ROS) [4–6]. It
has also been suggested to be involved in the regulation of
mitochondrial permeability transition pore [7]. And finally,
the 43rd subunit B16.6 of complex I has been found to be
homologous to human GRIM-19 protein which is thought to
be a part of the interferon-h- and retinoic acid-induced
pathway of cell death [8].
Little is known about regulation of complex I functions. It
has been shown that in vitro complex I undergoes a slow,
reversible active/de-active transition and that this transition
involves some (as yet non-identified) conformational change
[9,10]. It has also been reported that complex I may be
activated by mitochondrial cAMP-dependent protein kinase
phosphorylating the 18-kDa subunit of complex I [11].2. Nitric oxide biochemistry
NO is a small molecule, highly diffusible in water and
through biological membranes, so NO can easily diffuse
from one cell to the next. The main source of NO within the
cells is synthesis by three isoforms of NO synthase: two
G.C. Brown, V. Borutaite / Biochimica et Biophysica Acta 1658 (2004) 44–49 45constitutively expressed isoenzymes eNOS and nNOS and
the third, iNOS, which is induced during inflammation and
produces higher levels of NO for a longer period [12]. There
may also be a mitochondrial NOS (mtNOS), whose origin
and status is still unclear, but if mtNOS exists is probably
derived from eNOS, iNOS or nNOS [13,14]. NO may also
be produced nonenzymatically from nitrite at low pH ( < pH
5), e.g. during ischaemia [15].
NO itself at physiological concentrations (unclear, but
probably 0.1–100 nM) is relatively unreactive, and most of
its physiological actions are mediated by NO binding to
Fe2 + in the haem of soluble guanylate cyclase causing
activation and cGMP production [12]. NO may also bind
with high affinity to free Fe2 + or Fe2 + within any other
haem protein with a free ligand position, such as cyto-
chrome c oxidase or catalase. However, NO may be con-
verted to a number of more reactive derivatives, known
collectively as reactive nitrogen species (RNS) (Fig. 1). At
high concentrations (or within membranes) NO reacts
directly with oxygen to produce NO2, which rapidly reacts
with a further NO to give N2O3. NO2 may oxidise or nitrate
(add an NO2
+ group to) a variety of molecules, while N2O3
can nitrosate (add an NO+ group to) amines (to give N-
nitrosoamines) or thiols (to give S-nitrosothiols). Nitrosation
is often called nitrosylation, but the latter term should refer
to addition of NO (rather than NO+), e.g. to Fe2 +. NO reacts
at the diffusion-limited rate with O2
 to produce peroxyni-
trite (ONOO), which can oxidise or nitrate other mole-Fig. 1. Reactioncules, or can decay producing other damaging species
(possibly the hydroxyl radical OH
S
and NO2). NO may
indirectly (possibly via N2O3 or via NO reaction with RS
S)
nitrosate thiols (e.g. in proteins or glutathione) to give S-
nitrosothiols (RSNO, e.g. S-nitroso-glutathione and S-
nitroso-albumin). The NO+ group is directly transferable
between different S-nitrosothiols, a process known as trans-
nitrosation or transnitrosylation. S-nitrosated or tyrosine-
nitrated proteins may have altered function. S-nitrosothiols
can also release NO in the presence of either light or
reductants such as reduced thiols.3. NO effects on mitochondria
NO and RNS inhibit mitochondrial respiration by differ-
ent means: (A) NO itself causes rapid, selective, potent, but
reversible inhibition of cytochrome oxidase, and (B) RNS
cause slow, nonselective, weak, but irreversible inhibition of
many mitochondrial components [16–18]. The reversible
NO inhibition of cytochrome oxidase occurs at nanomolar
levels of NO and in competition with oxygen [19–21], so
that NO is potentially a physiological regulator of respira-
tion [22,23]. Peroxynitrite can inhibit complex I, complex
II, cytochrome oxidase (complex IV), the ATP synthase,
aconitase, Mn-SOD, creatine kinase, and probably many
other proteins [16,18,24]. Peroxynitrite is a strong oxidant
and can also induce lipid peroxidation and increase mito-s of NO.
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lipid peroxidation or thiol cross-linking) [24]. Apart from
inhibiting respiration, NO has two other relevant effects on
mitochondria: (1) induction of ROS and RNS production
from mitochondria [25], and (2) induction of mitochondrial
permeability transition by RNS [26,27].4. Mechanisms of NO inhibition of complex I
NO/RNS might inhibit complex I by several different
mechanisms, some of which have supporting evidence and
some are speculative: (i) release of iron from complex I
iron–sulfur (FeS) centres, (ii) reversible modification of Fe,
S or cysteine in FeS centres, (iii) S-nitrosation of cysteine
residues, (iv) oxidation of cysteine residues, (v) glutathio-
nylation of cysteine residues, (vi) N-nitrosation of second-
ary amines, e.g. in tryptophan residues, (vii) oxidation of
tryptophan residues, (viii) nitration of tyrosine residues, (ix)
modification of coenzymes NADH, ubiquinone or FMN, or
(x) oxidation of phospholipids. Inhibition could be mediated
by NO itself, any of the RNS: ONOO, NO2, N2O3, N2O4,
S-nitrosothiols or any of the ROS: O2
, H2O2 or OH
S
.
4.1. Discovery of macrophage NO and its role in cytostasis/
cytotoxicity of tumour cells
Historically the first reported complex I inhibition attrib-
utable to NO predates the discovery of biological NO, and
contributed to that discovery [28–31]. Inflammatory-acti-
vated macrophages were found to inhibit complex I (as well
as complex II and aconitase, but not other complexes)
within co-cultured tumour cells or cell lines or the macro-
phages themselves, and the inhibition depended on the
presence of L-arginine (substrate of NO synthase) [28–
31]. NO itself was subsequently found to cause complex I
inhibition within these cells, leading to the conclusion that
NO derived from the macrophages was inhibiting complex I
within the tumour cells [30]. That the respiratory inhibition
(by whatever mechanisms) mediated the killing and/or
cytostasis of tumour cells was suggested by the finding that
tumour cell death could be completely prevented by glucose
acting presumably as substrate for glycolysis and thus an
alternative source of ATP [31].
4.2. Damage to FeS centres
The inhibition of complex I, complex II and aconitase
induced by NO from the macrophages was attributed to NO-
induced damage to iron–sulfur centres and the release of
iron from these centres [29,31]. Cells exposed to NO or NO
from iNOS were subsequently found to exhibit a g = 2.04
electron paramagnetic resonance (EPR) signal characteristic
of dinitrosyl iron complexes Fe(NO)2(SR)2 [32], suggesting
that the iron was removed from susceptible iron sulfur
centres by NO reacting directly with the iron, displacingelemental sulfur or cysteine residues (Fig. 1C). However, it
was never shown that the dinitrosyl iron complex appearing
in NO-exposed cells was derived from mitochondrial iron–
sulfur centres, and indeed on quantitative grounds this
seemed unlikely.
Despite the lack of direct evidence that NO can remove
iron from iron–sulfur centres in complex I, it is clear that
NO can displace iron from other iron–sulfur centres, and
understanding how this occurs mechanistically may be of
some relevance to the actions of NO on complex I. High
concentrations of NO can destroy iron–sulfur centres by
binding and displacing the iron as dinitrosyl iron, and there
is EPR evidence for such damage in complex II [33], but not
so far in complex I. Reversible NO inactivation of E. coli
exonuclease III, ferredoxin and other iron–sulfur proteins
has been shown to be mediated by disruption of the iron–
sulfur centre to form a dinitrosyl iron complex (Fig. 1C),
which can be reconverted to the functional iron–sulfur
centre by reduced thiols [34]. NO can cause inactivation
of aconitase in some conditions that may involve catalytic
S-nitrosation of the iron–sulfur centre [35]. Peroxynitrite
can more rapidly inactivate aconitase via removal of one
particular labile iron atom of the active site 4Fe4S iron–
sulfur centre [36]. We might speculate that damage to
complex I iron–sulfur centres may start with NO reacting
with the iron (to form dinitrosyl iron), and/or the sulfide or
cysteine residues that bind the iron (to form RSNO) (Fig.
1C). This initial phase of inhibition may be reversible by
light or reduced thiols, but further reactions with the Fe or S
may completely disassemble the iron–sulfur centres and
thus irreversibly inhibit activity.
4.3. S-nitrosation of complex I
More recently, it was found that several cell types
exposed to NO for several hours developed an irreversible
inhibition of cellular respiration due specifically to inacti-
vation of complex I [23,37]. However, this inactivation of
complex I and respiration was completely reversed by either
light or reduced thiols, suggesting that the inactivation was
due to S-nitrosation of complex I (as S-nitrosation is
generally reversed by these treatments). This was an impor-
tant finding as it indicated: (a) that NO inhibition of cellular
respiration was mainly due to complex I inhibition, and (b)
the inhibition was reversible by specific agents indicating
potential mechanisms. However, there is no direct evidence
for S-nitrosation of complex I as yet, and reduced thiols and
light might potentially reverse other forms of NO inhibition
such as nitrosylation of iron.
The S-nitrosothiols: S-nitrosoglutathione (SNOG) and
S-nitrosoacetylpenicillamine (SNAP) can rapidly inactivate
complex I when added to isolated mitochondria, even in
conditions when little or no NO is released, and such
inhibition is reversed by light or reduced thiols (glutathi-
one or dithiothreitol), suggesting that the inactivation is
mediated by transnitrosation [38]. However, the inhibition
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as a poor S-nitrosating agent) is also partly reversed by
light and reduced thiols [38], suggesting that mechanisms
other than nitrosation might be involved or that peroxyni-
trite may nitrosate. Recently we found that NO and
calcium synergistically inhibited the complex I activity
and oxygen consumption of isolated mitochondria [39].
This inhibition was prevented by superoxide dismutase or
urate, suggesting that the inhibition was mediated by
peroxynitrite. And the inhibition was reversed by reduced
thiols or light suggesting that the inhibition (although
mediated by peroxynitrite) may involve S-nitrosation or
Fe-nitrosylation of complex I [39].
4.4. Tyrosine nitration by peroxynitrite
Long-term exposure of isolated mitochondria or submi-
tochodrial particles was reported to result in relatively
specific inhibition of complex I that was partially prevented
by superoxide dismutase or urate (a superoxide and perox-
ynitrite scavenger) implicating peroxynitrite as mediating
the inhibition [40]. The inhibition was not reversed by
reduced glutathione, suggesting S-nitrosation was not in-
volved, but was accompanied by tyrosine nitration of
complex I subunits, suggesting that nitration may mediate
the inhibition [40].
Others have also suggested that peroxynitrite inhibits
complex I by tyrosine nitration [41,42]. Addition of 0.2–2.0
mM peroxynitrite to isolated mitochondria has been shown
by several groups to result in inhibition of complex I,
complex II and complex V (the ATP synthase) with rela-
tively little affect on complexes III and IV [18,41,43,44].
Accompanying such inhibition there was tyrosine nitration
of five complex I peptides: the 49-kDa subunit (NDUFS2),
TYHY (NDUFS8), B17.2 (17.2-kDa differentiation associ-
ated protein), B15 (NDUFB4) and B14 (NDUFA6). How-
ever, the estimated level of nitration was low (a few percent)
except on peptides B14 and B15, and these peptides are not
thought to be involved in complex I respiratory activity
[42]. So it is still unclear whether tyrosine nitration mediates
peroxynitrite-induced inhibition of complex I.
Evidence of tyrosine nitration of mitochondrial complex
I subunits was found in an untreated dopaminergic SH-
SY5Y ‘‘neuronal’’ cell line using an antibody against
protein-bound 3-nitro tyrosine [41]. ONOO generating
SIN-1 induced apoptosis in these cells with concomitant
increase in tyrosine nitration and reduction in mitochon-
drial ATP synthesis. These results suggest that ONOO
may induce mitochondrial dysfunction and cell death in
neurons through nitration of mitochondrial complex I
subunits [41].
4.5. Other thiol modifications
Exposure of mitochondria or isolated complex I to SNAP
or oxidised glutathione (GSSG) resulted in blockage ofreduced thiols specifically on the 51-kDa and 75-kDa
subunits of complex I, which might result from S-nitro-
sation, oxidation or glutathionylation of cysteine residues
[45]. This thiol modification correlated in time with inhibi-
tion of complex I activity, but while thiol modification was
reversed by dithiothreitol and GSH, the inhibition was not
[45], suggesting either that the thiol modification is not
involved in inhibition or that thiol modification proceeds
from a reversible to an irreversible form.
Addition of peroxynitrite to mitochondria resulted in the
oxidation of a methionine and a tryptophan residue in the
B17.2 (DAP) subunit of complex I, although the extent of
oxidation was not quantified, and it is unclear whether such
modification in this subunit could inhibit complex activity
[42].5. Pathological relevance of NO inhibition of complex I
Whatever the mechanism, NO inhibition of complex I
may be important in cell pathology and disease. A decrease
in complex I activity and ATP levels has been observed in
skeletal muscle biopsies from critically ill patients in septic
shock; the decrease in complex I activity correlated with
increased clinical severity and NO production (and de-
creased GSH levels), and was suggested to be causative in
the pathology [46]. A rat model of septic shock reproduced
these findings in both skeletal muscle and liver [47].
Parkinson’s disease results from degeneration of dopa-
minergic neurons in the substantia nigra of the brain.
Degeneration is accompanied by substantial inhibition of
complex I activity in these cells, and complex I inhibitors
can result in symptoms similar or identical to the disease,
leading to the suggestion that complex I inhibition in the
cells leads to their degeneration and hence the disease [48].
NO or RNS, derived from inflammatory activated glia,
have been suggested as potential mediators of this complex
I inhibition [48], however, there is no direct evidence for
this. Inflammatory activation of a microglial (brain mac-
rophage) cell line resulted in iNOS expression and inhibi-
tion of mitochondrial respiratory complexes I and II and
aconitase, which was prevented by iNOS inhibition [49].
However, it was found that coculture of primary forebrain
neurons with iNOS-expressing astrocytes did not cause
complex I inactivation, unless cellular glutathione was
depleted, suggesting that glutathione protects complex I
from NO-induced inhibition [50]. Other authors found that
dopamine synergised with NO to inhibit complex I in
PC12 cells for reasons that are unclear, but this may
indicate that dopaminergic neurons are more susceptible
to NO inhibition of complex I [51].
Emotional stress also induced iNOS in rat brain, and
caused substantial inhibition of the apparent brain activities
of mitochondrial complexes I and II, which was prevented
by an iNOS inhibitor, suggesting that NO from iNOS may
inhibit mitochondrial complex activities in vivo [52].
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At least three mechanisms have been invoked in the NO
inhibition of complex I: S-nitrosation, tyrosine nitration and
damage to FeS centres. None of these mechanisms has been
definitively shown to mediate inhibition, although it is likely
that all three mechanisms, as well as others, occur. In some
conditions the NO inhibition of complex I is reversible by
light or reduced thiols, and this may indicate S-nitrosation or
Fe-nitrosylation. The inhibition of complex I appears to be
one of the most important means of NO-induced inhibition
of cellular respiration, at least in some conditions, although
other mitochondrial components are also inhibited. iNOS-
expressing cells and tissues exhibit an inhibition of complex
I, which might contribute to inflammatory pathology for
example in Parkinson’s disease and septic shock.Acknowledgements
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